PharmaLex

In the rapidly evolving world of regulatory requirements, navigating local affiliate pharmacovigilance can be challenging. Our expert guide provides you with detailed frameworks, insights, and best practices that are helping biopharma companies establish and maintain compliance with these complex requirements. What You Will Learn PV Outsourcing Strategies: Adapt to local regulatory requirements and market dynamics Six Essential Best Practices: Optimize your PV outsourcing activities for success Common Pitfalls: Identify the common mistakes that could jeopardize market authorization

Our Quality Management and Compliance (QMC) team is involved in all aspects of the Product Lifecycle from innovation to commercialisation providing strategic consultancy related to compliance in every stage from development to product withdrawal. From early innovation, we guide our clients through all stage gates towards and beyond commercialization, consulting with them on anything that will impact the quality and compliance of the final product.

EU Parliament Proposes Major Revisions to MDR and IVDR! On October 23, 2024, the European Parliament adopted a joint motion for a resolution addressing the urgent need to revise the Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) (2024/2849(RSP)). Next Steps: 1. European Commission to propose amendments to the MDR and IVDR by the end of Q1 2025. 2. Submission of the proposal to the Council and the European Parliament. 3. Legislative process. 4. Final adoption and implementation.

Transform Your MedTech Journey with Our Insights Hub! Navigating the intricate world of medical technology doesn’t have to be daunting. Our MedTech Insights Hub offers solutions that span the entire product lifecycle—from medical devices and in-vitro diagnostics to digital therapeutics and combination products. Our experts are dedicated to simplify processes, enhance efficiencies, and tackle regulatory complexities across North America, Europe, and Asia Pacific. With tailored strategies and in-depth regulatory insights, we empower you to attain success from innovation to commercialization.

Unlocking the Future of Personalized Medicine! 🧬 Discover why companion diagnostics (CDx) are revolutionizing healthcare by tailoring treatments to individual patients' unique biological profiles. Dive into our latest article to learn how CDx is enhancing treatment efficacy, minimizing adverse effects, and optimizing resource allocation.

Join our on-demand webinar, "Driving Product Launch Success in Europe," and discover how to navigate the challenges and plan a successful launch for your medicinal product in the EU, UK, and Switzerland. Key Takeaways: • Overcome regulatory and supply chain hurdles • Master timelines and planning for market success • Learn from a real-world success story Featuring Regina Dawkins, an experienced Director and Principal Consultant with 30 years in the pharma industry, sharing her wealth of knowledge and insights.